US OptionsDetailed Quotes
NVO241227C85000
- 2.33
- -0.37-13.70%
15min DelayClose Dec 27 16:00 ET
3.60High2.30Low
3.01Open2.70Pre Close280 Volume1.66K Open Interest85.00Strike Price87.65KTurnover2180.43%IV-0.05%PremiumDec 27, 2024Expiry Date2.37Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9867Delta0.0318Gamma37.18Leverage Ratio-142.4684Theta0.0000Rho36.68Eff Leverage0.0000Vega
Novo-Nordisk A/S Stock Discussion
Sign in to post a comment
$Novo-Nordisk A/S (NVO.US)$ premarket bulltrap
3
2
Morning Movers
Gapping up
$Novo-Nordisk A/S (NVO.US)$ shares rose 5%, recovering from an 18% drop in the previous session after its weight loss drug, CagriSema, posted disappointing late-stage trial results on Friday.
$Tesla (TSLA.US)$ gained 3% premarket, recovering from last week's 3.5% drop, its worst performance since before the U.S. presidential election.
$Traws Pharma (TRAW.US)$ shares surged 109% after announcing progress on...
Gapping up
$Novo-Nordisk A/S (NVO.US)$ shares rose 5%, recovering from an 18% drop in the previous session after its weight loss drug, CagriSema, posted disappointing late-stage trial results on Friday.
$Tesla (TSLA.US)$ gained 3% premarket, recovering from last week's 3.5% drop, its worst performance since before the U.S. presidential election.
$Traws Pharma (TRAW.US)$ shares surged 109% after announcing progress on...
25
1
14
$Novo-Nordisk A/S (NVO.US)$ Statistics are always open to interpretation. Never a 100 percent correct evaluation. In doing so, Novo also point out a number of RESEARCH LIMITATIONS. Less than SIX out of TEN obese patients would have used the highest permitted dose. Nevertheless, Novo Nordisk will ask the regulators of the pharmaceutical industry to allow the drug for commercialization.
So, would you care if a weight loss supplement only achieved a 22.7% weight ...
So, would you care if a weight loss supplement only achieved a 22.7% weight ...
$Novo-Nordisk A/S (NVO.US)$ 150 by this year
4
1
$Novo-Nordisk A/S (NVO.US)$ why the drop
1
1
$Novo-Nordisk A/S (NVO.US)$ Waoooo so cheapp now
1
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
$Novo-Nordisk A/S (NVO.US)$
no idea whats up w/ nvo for entry but nvox is a new leaveraged ticker. it just started recently so hadn't had a chance to go up yet before tanking. this is the complete history of ticker.
$Defiance Daily Target 2X Long NVO ETF (NVOX.US)$
no idea whats up w/ nvo for entry but nvox is a new leaveraged ticker. it just started recently so hadn't had a chance to go up yet before tanking. this is the complete history of ticker.
$Defiance Daily Target 2X Long NVO ETF (NVOX.US)$
7
Devastating Crash of $Novo-Nordisk A/S (NVO.US)$ and Strong Rebound of $NVIDIA (NVDA.US)$ on Black Friday.
I made a difficult but crucial decision on Friday to sell off losing positions at pre-market which were moving downtrend so badly like $Novo-Nordisk A/S (NVO.US)$ , $D.R. Horton (DHI.US)$ , $Huntington Ingalls Industries (HII.US)$ , $MarketAxess (MKTX.US)$ . Especially obesity drug giant NVO which collapsed 25% at pre-market after disappointing trial results o...
I made a difficult but crucial decision on Friday to sell off losing positions at pre-market which were moving downtrend so badly like $Novo-Nordisk A/S (NVO.US)$ , $D.R. Horton (DHI.US)$ , $Huntington Ingalls Industries (HII.US)$ , $MarketAxess (MKTX.US)$ . Especially obesity drug giant NVO which collapsed 25% at pre-market after disappointing trial results o...
loading...
9
No comment yet
104176897 : Thrash the shortie